Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
34 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsBasilea presents preclinical data on its anticancer drug candidate BAL101553 at EORTC-NCI-AACR symposium
(WorldNews Switzerland)

 
 

14 november 2018 11:13:32

 
Basilea presents preclinical data on its anticancer drug candidate BAL101553 at EORTC-NCI-AACR symposium
(WorldNews Switzerland)
 


Late-breaking abstracts on increased cure rates and synergistic effects of combinations with eribulin and gemcitabine in solid tumor models Enhanced survival in a brain tumor model after single agent treatment Basel, Switzerland, November 14, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it is presenting new preclinical data on its clinical stage anticancer drug candidate BAL101553 at the 30th EORTC-NCI-AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland, November 13-16, 2018. Two posters are presented in the late-breaking abstract session. Late-breaking abstracts are selected to highlight novel and potentially practice-changing studies,...


 
5 viewsCategory: General > Europe > Switzerland
 
Nokia, ABB and Kalmar conduct industry´s first trial with ultra-reliable low-latency 5G technology
(WorldNews Switzerland)
Baloise is on track
(WorldNews Switzerland)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten